Palvella Therapeutics (PVLA) Curent Deferred Tax Liability (2013 - 2015)

Palvella Therapeutics (PVLA) has 3 years of Curent Deferred Tax Liability data on file, last reported at $24464.0 in Q3 2015.

• Curent Deferred Tax Liability for Q3 2015 came in at $24464.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2015 was $24464.0 (changed N/A YoY), and the FY2014 annual result was $26522.0, up 40.5% from the prior year.
• Curent Deferred Tax Liability held at $24464.0 in Q3 2015 per PVLA's latest filing, from $24446.0 in the prior quarter.
• Over five years, Curent Deferred Tax Liability peaked at $26522.0 in Q4 2014 and troughed at $18877.0 in Q4 2013.
• A 3-year average of $23570.0 and a median of $24446.0 in 2015 frame the typical range for Curent Deferred Tax Liability.
• On a YoY basis, Curent Deferred Tax Liability climbed as much as 40.5% in 2014 and fell as far as 40.5% in 2014.
• A 3-year view of Curent Deferred Tax Liability shows it stood at $18877.0 in 2013, then soared by 40.5% to $26522.0 in 2014, then retreated by 7.76% to $24464.0 in 2015.
• Business Quant data shows PVLA's Curent Deferred Tax Liability at $24464.0 in Q3 2015, $24446.0 in Q2 2015, and $23541.0 in Q1 2015.